ArticleCell death discovery2026

BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability.

Sara Franceschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.